Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Buys Biochemicals Firm Research Organics

NEW YORK (GenomeWeb News) – Sigma-Aldrich announced after the close of the market on Monday that it has acquired high purity biochemicals firm Research Organics for an undisclosed amount.

Founded in 1953 and based in Cleveland, Research Organics supplies biochemicals for use in molecular biology, diagnostics, cell culture, pharmaceuticals, biopharmaceuticals, life sciences, and biotechnology. Its portfolio includes biological buffers, molecular biology grade products, reagent biochemicals, and other products.

The deal, Sigma-Aldrich said, is expected to expand that firm's buffer production capacity and increase the size of its portfolio of PharmaGrade raw materials for the diagnostics and biopharmaceuticals markets.

Research Organics will be folded into SAFC, the custom manufacturing and services business unit of Sigma-Aldrich, which said the deal is anticipated to be neutral to earnings per share in 2012.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.